- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Glaucoma 2007: the year in review
Although 2007 did not present groundbreaking news for the specialty of glaucoma, several small advances occurred-particularly in the area of diagnostics. In addition, some new or investigational surgical modalities are showing promise as safe and effective methods for controlling IOP. The year also was a time for consolidation as specialists took stock of emerging knowledge, reassessed existing dogma, and determined what directions to pursue in the future.
Key Points
In interviews with Ophthalmology Times, Robert D. Fechtner, MD, Joel S. Schuman, MD, and Robert N. Weinreb, MD, provided insights about some of the most important recent events shaping glaucoma patient care.
Diagnostics
"These are all helpful advances for the user, and we can expect in the future to see a trend-based analysis for [this OCT device] that will provide information on whether change is focal or global and where it is occurring spatially," said Dr. Schuman, professor and chairman, Department of Ophthalmology, and director of the University of Pittsburgh Medical Center Eye Center.
